PERSPECTA

News from every angle

← Back to headlines

BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo

26 Feb, 17:36 — 26 Feb, 17:36
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo5d ago

BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo

Read full article →

Related Stories

Marquette National Reports GAAP EPS of $3.01

16m ago

Eaton Vance Tax-Managed Glbl Buy-Write Oppty Fund declares $0.0664 dividend

17m ago

Eaton Vance Tax-Managed Diversified Eqty Inc Fund declares $0.0992 dividend

18m ago

PM Discusses Stranded Australians with UAE Leader

19m ago